Nicholas Kovacevich, Co-Founder and CEO of Kush Bottles, said that the company is in a unique position to launch new products. “We’ve done a great job at growing our distribution network throughout each state with a cannabis program,” he said. “As our industry expands, we expand our portfolio by developing products that meet the emerging needs of our customers,” he added. “Developing product lines that better meet our customers’ needs is a vital part of our strategy.”
BudGloves™ are available for purchase through the company’s website for $8.99 a box, at: www.kushbottles.com, or by calling: 888-920-5874.
About Kush Bottles:
Kush Bottles recently became a publicly traded company and is one of the few cannabis-based businesses on the public markets that has demonstrated profitability and revenue growth, without direct involvement with the actual cannabis plant or extract.
Kush Bottles is a leading packaging provider, offering certified child-resistant and custom-branded solutions in all states that permit medical or adult cannabis use, as well as in Canada.
With over 100 million bottles sold, the company is respected for its premium quality products, exceptional customer service, fast deliveries, and innovative custom solutions.
Kush Bottles has been featured in media nationwide, including CNBC, Los Angeles Times, TheStreet.com, and Inc. Magazine.
For more information, visit www.kushbottles.com or call (888)-920-5874.
Forward Looking Statements:
This press release includes statements considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent our current judgments, they are subject to risks and uncertainties that could cause actual results to differ. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, and risk inherent with operations of a company. Reader is cautioned not to place undue reliance on forward-looking statements, which reflect opinions only as of the date of this release. We are not obligated to revise any forward-looking statements in light of new information.